AbbVie
The Senior Director Process Engineering Peptides API sets enterprise direction and technical governance for process engineering strategy, platform deployment, and project delivery for biologics and cell and gene therapy manufacturing. This role partners with strategic investments, manufacturing sites, and cross-functional teams to deliver robust engineering solutions and support new production capabilities. The position involves establishing global engineering standards, providing technical leadership for capital investments, and building engineering capability across the organization.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Associate Director Process Engineering - Peptides API
Eli Lilly and Company
Associate Director Process Engineering - Peptides API
Eli Lilly and Company
Associate Director - Engineering API External Manufacturing Peptides & Large Molecules
Eli Lilly and Company
CART Scientist
Artech
Senior Consultant
Syner-G
Director, International CMC Regulatory Affairs – Cell and Gene Therapy
AstraZeneca